New Study: ACT for Chronic Headache Pain

New Study: ACT for Chronic Headache Pain

The Study
In a study recently published in the journal Headache, preliminary evidence was found to support to use of ACT for chronic headache pain.  The study aimed to examine the efficacy of group-based ACT treatment for reducing the experience of pain, disability, and affective distress due to recurrent episodes of headache pain.  The study sample consisted of outpatient Iranian women.
ACT has been validated through numerous studies to date for chronic pain and has been given the highest grade of evidenced-based backing by APA division 12, ‘strong research support’.  While division 12 includes headache pain within the general category if chronic pain, there has been a gap in the literature to date regarding the efficacy of ACT specifically with severe and chronic headache pain.
The results of the study indicated that the addition of 8 weeks of ACT group treatment (in addition to treatment-as-usual) produced significant reductions in disability and affective distress due to pain.  However there were not significant reductions in sensory experience of pain.
What Does This Mean
These findings are consistent with similar studies in that ACT treatment does not tend to reduce pain intensity itself, but rather reduces pain-related disability and affective distress related to how the person copes with the pain. ACT aims to help the person change their relationship with pain, so that they can hold it more gently and spend less time in pain-related rumination. This aspect of ACT is similar to other mindfulness-based interventions, such as Mindfulness-Based Stress Reduction. In addition to changing one’s relation to pain, another major focus of  ACT is increasing engagement with valued life domains such as work, play, exercise, and flexibly moving on with life even as pain occurs. This aspect is relatively less emphasized in most other mindfulness-based therapies and is a unique contribution of ACT
The Takeaway
The evidence supporting the use of ACT for chronic pain is strong. This study further elaborates the kinds of chronic pain problems that ACT can be applied to, suggesting that ACT might work well in the area of chronic headache pain.

For further information and news on evidenced-based treatment for headache pain, please see the author’s website – Headaches101.com.

UPCOMING TRAINING EVENTS

ACT Precision Training: In-Session Case Conceptualization in Acceptance and Commitment Therapy to Help You be Focused and Strategic in Your Interventions

Jason Luoma, Ph.D. and Jenna LeJeune, Ph.D
June 18, 2021 from 12-2pm

This workshop provides a chance to learn and practice in-session, in-the-moment case conceptualization of cases from the perspective of Acceptance and Commitment Therapy. This workshop focuses on helping you use ACT theory & in-session clinical markers to make more precise and strategic interventions. The main goal of this workshop is to help you become more adept at identifying in-session client behaviors that are indicators for particular ACT processes that are likely to be most relevant. The workshop uses a process we call ACT Circuit Training, which involves intensive analysis of a video of an ACT session and intentional practice in conceptualizing client behavior and generating possible ACT responses, followed by discussion and feedback. Read More.


ACT Agility Training: In-Session Case Conceptualization in Acceptance and Commitment Therapy to Increase Flexible Responding

Jason Luoma, Ph.D. and Jenna LeJeune, Ph.D
July 16, 2021 from 12-2pm

This workshop provides a chance to learn and practice in-session, in-the-moment case conceptualization of cases from the perspective of Acceptance and Commitment Therapy. This workshop is intended to help therapists be more flexible and nimble in their use of ACT processes, strengthening their ability to fluidly shift as needed between processes within sessions. Therapist learning ACT often develop tunnel vision, focusing too much on particular processes or responding rigidly when more flexibility is needed. Read More.


Therapy and Research in Psychedelic Science (TRIPS) Seminar Series

Second Friday of each month from 12:00 PM – 1:00 PM (PT)

TRIPS is an online seminar series that hosts speakers discussing science-informed presentations and discussions about psychedelics to educate healthcare professionals. This series was created to guide healthcare providers and students preparing to be professionals towards the most relevant, pragmatic, and essential information about psychedelic-assisted therapy, changing legal statuses, and harm reduction approaches in order to better serve clients and communities. This seminar series is a fundraiser for our clinical trial of MDMA-assisted psychotherapy for social anxiety disorder that Portland Psychotherapy investigators are preparing for and starting in the Fall of 2021. All proceeds after presenter remuneration will go to fund this clinical trial. Read more.

September 10th, 2021 – Cultural Considerations in Outreach to and Assessment of Minoritized/Marginalized Individuals in Psychedelic-Assisted Psychotherapy with Terence Ching, Ph.D.